Back to search
FDAFDA · Food and drugs·Recall number D-0007-2025

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

Published October 9, 2024 · Recall initiated: September 23, 2024

Summary

FDA records drug Class II recall D-0007-2025, published October 9, 2024 and initiated September 23, 2024. Recalling firm: Advanced Accelerator Applications USA, Inc.; Status: Ongoing; Reported quantity: 99 doses; Lot: Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Advanced Accelerator Applications USA, Inc.
Distributor
FL, MA, NJ, NY, PA, and VA
Lot
Lot#: LPS240919B-16, 24-Sep-2024 Lot#: LPS240920B-16, 25-Sep-2024 Lot#: LPS240920C-16, 25-Sep-2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61 recalled?

Yes. FDA published recall D-0007-2025 on October 9, 2024. Reported hazard: CGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter